John F. Kennedy Medical Center, an affiliate of Hackensack Meridian Health, is a 499-bed full-service, acute care hospital, and the home of the JFK Johnson Rehabilitative Institute.

There are 499 beds in John F Kennedy Medical Center.

During the past decade, John F Kennedy Medical Center conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 25 clinical trials were completed, i.e. on average, 108.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 11 clinical trials were completed. i.e. 122.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "John F Kennedy Medical Center" #1 sponsor was "Radiation Therapy Oncology Group" with 41 trials, followed by "National Cancer Institute (NCI)" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Precision Life Sciences Group" with 3 trials sponsored and "Tocagen Inc." with 3 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "John F Kennedy Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Radiation Therapy Oncology Group" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "John F Kennedy Medical Center" are "Head and Neck Cancer" (8 trials), "Lung Cancer" (8 trials), "Brain and Central Nervous System Tumors" (7 trials), "Prostate Cancer" (7 trials) and "Glioblastoma" (6 trials). Many other conditions were trialed in "John F Kennedy Medical Center" in a lesser frequency.

Most popular intervention types in "John F Kennedy Medical Center" are "Drug" (69 trials), "Radiation" (43 trials), "Procedure" (22 trials), "Biological" (18 trials) and "Other" (12 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (34 trials), "Placebo" (11 trials), "conventional surgery" (10 trials), "cisplatin" (9 trials) and "Temozolomide" (7 trials). Other intervention names were less common.

The vast majority of trials in "John F Kennedy Medical Center" are 91 trials for "All" genders, 6 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "John F Kennedy Medical Center". undefined are not yet recruiting, 2 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 77 completed trials in John F Kennedy Medical Center, 1 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in John F Kennedy Medical Center, 15 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".